1297 related articles for article (PubMed ID: 19308751)
1. Maternal serum endostatin at gestational weeks 16-20 is elevated in subsequent pre-eclampsia but not in intrauterine growth retardation.
Wathén KA; Ylikorkala O; Andersson S; Alfthan H; Stenman UH; Vuorela P
Acta Obstet Gynecol Scand; 2009; 88(5):593-8. PubMed ID: 19308751
[TBL] [Abstract][Full Text] [Related]
2. Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation.
Wathén KA; Tuutti E; Stenman UH; Alfthan H; Halmesmäki E; Finne P; Ylikorkala O; Vuorela P
J Clin Endocrinol Metab; 2006 Jan; 91(1):180-4. PubMed ID: 16263826
[TBL] [Abstract][Full Text] [Related]
3. sCD40 ligand determined in maternal and umbilical cord blood in pregnancies complicated by pre-eclampsia with and without intrauterine growth retardation.
Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
Gynecol Obstet Invest; 2007; 64(1):8-13. PubMed ID: 17199090
[TBL] [Abstract][Full Text] [Related]
4. Serum endostatin and vascular endothelial growth factor levels in patients with pre-eclampsia.
Mahmound RA; Abdel-Raouf M
East Mediterr Health J; 2006; 12(1-2):178-87. PubMed ID: 17037236
[TBL] [Abstract][Full Text] [Related]
5. First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction.
Chafetz I; Kuhnreich I; Sammar M; Tal Y; Gibor Y; Meiri H; Cuckle H; Wolf M
Am J Obstet Gynecol; 2007 Jul; 197(1):35.e1-7. PubMed ID: 17618748
[TBL] [Abstract][Full Text] [Related]
6. Proteinuria in pre-eclampsia: how much matters?
Chan P; Brown M; Simpson JM; Davis G
BJOG; 2005 Mar; 112(3):280-5. PubMed ID: 15713140
[TBL] [Abstract][Full Text] [Related]
7. First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk.
Khalil A; Cowans NJ; Spencer K; Goichman S; Meiri H; Harrington K
Prenat Diagn; 2009 Aug; 29(8):781-9. PubMed ID: 19418482
[TBL] [Abstract][Full Text] [Related]
8. Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia.
Papadopoulou E; Sifakis S; Giahnakis E; Fragouli Y; Karkavitsas N; Koumantakis E; Kalmanti M
Growth Horm IGF Res; 2006; 16(5-6):290-6. PubMed ID: 16996762
[TBL] [Abstract][Full Text] [Related]
9. Increase in serum concentrations of inhibin in early onset pre-eclampsia with intrauterine growth restriction.
Itoh Y; Suzuki Y; Yamamoto T; Kojima K; Murakami I; Suzumori N
J Obstet Gynaecol Res; 2006 Feb; 32(1):80-5. PubMed ID: 16445530
[TBL] [Abstract][Full Text] [Related]
10. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia.
Chaiworapongsa T; Romero R; Kim YM; Kim GJ; Kim MR; Espinoza J; Bujold E; Gonçalves L; Gomez R; Edwin S; Mazor M
J Matern Fetal Neonatal Med; 2005 Jan; 17(1):3-18. PubMed ID: 15804781
[TBL] [Abstract][Full Text] [Related]
11. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
Spencer K; Cowans NJ; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Oct; 32(5):622-6. PubMed ID: 18816493
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum activin A levels in association with intrauterine fetal growth restriction.
Wallace EM; Schneider-Kolsky ME; Edwards A; Baker L; Jenkin G
BJOG; 2003 Mar; 110(3):306-10. PubMed ID: 12628273
[TBL] [Abstract][Full Text] [Related]
13. Decreased serum levels of kisspeptin in early pregnancy are associated with intra-uterine growth restriction and pre-eclampsia.
Armstrong RA; Reynolds RM; Leask R; Shearing CH; Calder AA; Riley SC
Prenat Diagn; 2009 Oct; 29(10):982-5. PubMed ID: 19582702
[TBL] [Abstract][Full Text] [Related]
14. [Predictive value of serum soluble fms-like tyrosine kinase 1 concentration in preeclampsia at second trimester].
Ye YH; Liu L; Zhan Y; Peng W
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):433-5. PubMed ID: 17083803
[TBL] [Abstract][Full Text] [Related]
15. First-trimester maternal serum activin A in pre-eclampsia and fetal growth restriction.
Ong CY; Liao AW; Munim S; Spencer K; Nicolaides KH
J Matern Fetal Neonatal Med; 2004 Mar; 15(3):176-80. PubMed ID: 15280143
[TBL] [Abstract][Full Text] [Related]
16. Endostatin levels and the risk of subsequent preeclampsia.
Thissier-Levy S; Boucoiran I; Luo ZC; Nuyt AM; Julien P; Fraser WD; Audibert F
Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):396-400. PubMed ID: 23958573
[TBL] [Abstract][Full Text] [Related]
17. Endothelin system in normal and hypertensive pregnancy.
Slowinski T; Neumayer HH; Stolze T; Gossing G; Halle H; Hocher B
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():446S-449S. PubMed ID: 12193142
[TBL] [Abstract][Full Text] [Related]
18. The role of the anti-angiogenic factor endostatin in intrauterine growth restriction.
Malamitsi-Puchner A; Boutsikou T; Economou E; Makrakis E; Iliodromiti Z; Kouskouni E; Hassiakos D
J Soc Gynecol Investig; 2005 Apr; 12(3):195-7. PubMed ID: 15784505
[TBL] [Abstract][Full Text] [Related]
19. Correlation between second trimester maternal serum inhibin-A and human chorionic gonadotrophin for the prediction of pre-eclampsia.
Aquilina J; Maplethorpe R; Ellis P; Harrington K
Placenta; 2000; 21(5-6):487-92. PubMed ID: 10940198
[TBL] [Abstract][Full Text] [Related]
20. Free fetal DNA is not increased before 20 weeks in intrauterine growth restriction or pre-eclampsia.
Crowley A; Martin C; Fitzpatrick P; Sheils O; O'Herlihy C; O'Leary JJ; Byrne BM
Prenat Diagn; 2007 Feb; 27(2):174-9. PubMed ID: 17191257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]